Therefore, a series of inflammatory biomarkers, such as c-reactive protein (CRP), neutrophil lymphocyte ratio (NLR) and Glasgow prognostic score (GPS) have been evaluated to predict the prognosis in several cancers [8–12]. The gene discussed is CRP; the disease is cancer.